BrightMeds vs MEDVi: Semaglutide and Tirzepatide Pricing Compared

Last reviewed: September 5, 2026 Last updated: September 5, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

PlexusDx publishes this comparison and is one of the providers discussed. We use the same evidence rules for our own program and competing programs.

The short answer

BrightMeds delivers lower compounded GLP-1 pricing than MEDVi on both semaglutide and tirzepatide, whether you compare month-to-month rates or prepaid plans. BrightMeds charges $129/month for semaglutide injection and $149/month for tirzepatide injection on a month-to-month basis; MEDVi charges $299/month for semaglutide refills and $399/month for tirzepatide refills after an introductory first-month rate. BrightMeds also offers state-limited three-month prepaid promotional plans that push the per-month equivalent lower still. MEDVi includes unlimited support and allows dose escalation without price increases; BrightMeds claims all-inclusive pricing with no membership or lab fees. Both programs ship medication, include provider consultations, and permit cancellation anytime. Below we walk through checkout-verified pricing, normalize the plans over twelve months, and map decision factors.

At-a-glance pricing comparison

All figures captured September 4, 2026. MTM = month-to-month.

BrightMeds pricing detail

BrightMeds publishes two pricing paths for compounded semaglutide and tirzepatide injections: a month-to-month plan and a state-limited three-month prepaid promotional plan. The month-to-month rate for semaglutide injection is $129/month, and for tirzepatide injection $149/month. Both prices include medication, provider evaluation, follow-up, dose adjustments, support, and shipping, with no membership, lab, or prescribing fee.

The three-month prepaid promotional plan charges $297 total for semaglutide (a $99/month equivalent when prepaid) and $357 total for tirzepatide (a $119/month equivalent when prepaid). These promotional rates are summer offers available in select states. Because the promotional plan requires prepayment of three months at once, you commit $297 or $357 upfront rather than paying monthly. BrightMeds does not require prepayment for the standard month-to-month option, and either plan permits cancellation anytime.

BrightMeds twelve-month cost calculations (our calculation)

• Semaglutide injection, month-to-month: $129/month × 12 = $1,548/year
• Tirzepatide injection, month-to-month: $149/month × 12 = $1,788/year
• Semaglutide injection, 3-month prepaid repeated: $297 per cycle × 4 cycles = $1,188/year
• Tirzepatide injection, 3-month prepaid repeated: $357 per cycle × 4 cycles = $1,428/year

The prepaid promotional calculations assume you remain eligible and renew at the promotional rate every three months. Confirm eligibility and renewal terms at checkout.

MEDVi pricing detail

MEDVi offers compounded semaglutide and tirzepatide injections on a month-to-month refill basis with no membership fee. The checkout-verified structure separates an introductory first-month rate from the standard refill rate. For semaglutide injection, the first month costs $179, and every subsequent refill costs $299/month. For tirzepatide, the first month costs $279, and refills cost $399/month. MEDVi also offers compounded semaglutide in tablet (oral) form; the tablet route adds $70 to the injection price, yielding a first-month rate of $249 and a refill rate of $369/month for oral semaglutide.

Each MEDVi price includes medication, provider consult, unlimited support, and shipping. Dose increases during treatment do not raise the monthly rate. MEDVi permits cancellation anytime with no contract obligation.

MEDVi twelve-month cost calculations (our calculation)

• Semaglutide injection, ongoing refill rate only: $299/month × 12 = $3,588/year
• Tirzepatide injection, ongoing refill rate only: $399/month × 12 = $4,788/year
• Semaglutide injection, including first-month discount: $179 (month 1) + $299 × 11 = $3,468 first year
• Tirzepatide injection, including first-month discount: $279 (month 1) + $399 × 11 = $4,668 first year

The introductory rate applies once. Starting in month two and continuing indefinitely, you pay the standard refill rate.

PlexusDx pricing detail

PlexusDx offers compounded semaglutide injection at $189/month month-to-month, $169/month with a three-month commitment, and $149/month with a six-month commitment. Compounded tirzepatide injection costs $289/month month-to-month, $269/month on a three-month commitment, and $249/month on a six-month commitment. Every price holds across all dose levels and includes medication, provider consultation, and shipping. There is no membership fee.

PlexusDx also provides compounded semaglutide in oral capsule form at $289/month and tirzepatide oral capsules at $349/month, both month-to-month. A microdose GLP-1 maintenance option runs $129/month. Each PlexusDx program includes a free check-in with a Doctor of Pharmacy; an optional genetic response test costs $298 standalone or $99 for active program members.

PlexusDx twelve-month cost calculations (our calculation)

• Semaglutide injection, month-to-month: $189/month × 12 = $2,268/year
• Tirzepatide injection, month-to-month: $289/month × 12 = $3,468/year
• Semaglutide injection, 6-month commitment: $149/month × 12 = $1,788/year
• Tirzepatide injection, 6-month commitment: $249/month × 12 = $2,988/year

Like-for-like plan comparison

Month-to-month plans permit the most direct comparison because they carry no prepayment or commitment obligation. On this basis, BrightMeds charges $129/month for semaglutide injection and $149/month for tirzepatide injection. MEDVi charges $299/month for semaglutide refills and $399/month for tirzepatide refills after the first month. PlexusDx sits in the middle at $189/month for semaglutide and $289/month for tirzepatide, both month-to-month. BrightMeds delivers the lowest month-to-month cost in both categories.

When commitment or prepaid plans enter the comparison, BrightMeds' three-month prepaid promotional pricing (where available) produces a $99/month equivalent for semaglutide and $119/month equivalent for tirzepatide, both lower than any competitor month-to-month or commitment rate in this comparison. PlexusDx's six-month commitment brings semaglutide to $149/month and tirzepatide to $249/month, matching BrightMeds' standard tirzepatide month-to-month rate and running $20/month higher than BrightMeds' semaglutide month-to-month rate. MEDVi does not offer multi-month commitment discounts.

Sema = semaglutide injection; Tirz = tirzepatide injection. BrightMeds prepaid figures are promotional rates requiring upfront payment of three months; PlexusDx commitment figures are billed monthly. All figures captured September 4, 2026.

Decision factors beyond the monthly rate

Promotional pricing and geographic eligibility

BrightMeds' three-month prepaid promotional rates are state-limited summer offers. If you live outside the eligible states or the promotion expires, you revert to the standard month-to-month rate. MEDVi's first-month introductory rate applies nationwide and requires no prepayment, but it ends after month one; every subsequent refill uses the higher standard rate. Confirm current promotional eligibility and expiration dates at checkout before committing.

Prepayment versus monthly billing

BrightMeds' promotional pricing requires you to pay $297 or $357 upfront for three months of medication. If your clinical course changes, you adjust dose mid-cycle, or you experience side effects that interrupt treatment, you have already paid. MEDVi and PlexusDx bill monthly, so you pay only for the medication you receive each month and can pause or cancel without forfeiting future months.

Dose escalation and price stability

All three providers hold the monthly rate constant as your clinician titrates your dose upward. BrightMeds, MEDVi, and PlexusDx each state that dose increases do not raise the price. This matters during the initial titration period when many patients move from starting doses to maintenance doses over several months.

Support and clinical resources

MEDVi includes unlimited support in every plan and emphasizes access to the care team throughout treatment. BrightMeds claims all-inclusive pricing with follow-up and adjustments included. PlexusDx includes a free check-in with a Doctor of Pharmacy and offers an optional genetic response test ($99 for active members) that uses genetic markers to predict GLP-1 response and side-effect risk. Neither BrightMeds nor MEDVi advertises a genetic response option.

Review and reputation snapshot

BrightMeds holds a 4.8-star rating on Trustpilot with over 900 reviews (captured September 4, 2026). MEDVi holds a 4.3-star rating with approximately 15,000 reviews on the same platform and capture date. PlexusDx holds a 4.2-star rating on Trustpilot, with 76% of reviews at five stars and 81% at four stars or higher (captured September 4, 2026). Review volume and rating distributions suggest broad patient engagement across all three programs, with BrightMeds showing the highest average rating and MEDVi the largest review base.

Choose BrightMeds if…

• You want the lowest advertised month-to-month rate for semaglutide or tirzepatide injection and live in a state where the service is available.
• You qualify for and prefer the three-month prepaid promotional plan and can commit the upfront payment.
• You value a higher Trustpilot rating and straightforward all-inclusive pricing with no membership or hidden fees.
• You do not require genetic response analysis or branded medication pathways.

Choose MEDVi if…

• You prefer month-to-month flexibility without prepayment or multi-month commitment.
• You value unlimited support and a large, established user base reflected in the extensive Trustpilot review count.
• You want access to both compounded injection and oral tablet routes for semaglutide under one provider.
• You plan to escalate dose during treatment and want assurance that the monthly rate will not increase.

Where PlexusDx fits

PlexusDx sits between BrightMeds and MEDVi on price. The month-to-month rate for semaglutide injection ($189/month) runs $60/month higher than BrightMeds and $110/month lower than MEDVi's refill rate. The six-month commitment ($149/month for semaglutide, $249/month for tirzepatide) narrows the gap with BrightMeds' standard month-to-month rate and undercuts MEDVi significantly. PlexusDx adds a Doctor of Pharmacy check-in at no extra charge and offers an optional genetic response test that uses FDA-recognized genetic markers to predict GLP-1 metabolism, efficacy, and side-effect risk. This combination suits patients who want mid-tier pricing, structured clinical support, and the option to integrate genetic data into prescribing decisions. PlexusDx also offers oral semaglutide and tirzepatide capsules and a microdose maintenance protocol at $129/month, providing route and intensity flexibility under one program.

Methodology and freshness

We captured BrightMeds pricing from the provider's public promotional page and MEDVi pricing by completing the checkout flow on September 4, 2026. PlexusDx pricing is current as of the same date. Twelve-month cost projections are our calculation, derived by multiplying stated monthly rates or summing prepaid cycles. We label all promotional and introductory rates explicitly and pair them with standard refill or month-to-month figures so you see both the entry cost and the recurring cost. Review ratings and volumes were recorded from Trustpilot on September 4, 2026. No figure in this article reflects discount offers or unpublished rates. Confirm all pricing, promotional eligibility, and plan terms at checkout before committing.

Frequently Asked Questions

Does BrightMeds' prepaid promotional rate renew automatically at the same price?

BrightMeds describes the three-month prepaid option as a state-limited summer promotional offer. Renewal at the promotional rate is not guaranteed; confirm renewal terms and pricing at checkout before each cycle.

Does MEDVi's first-month discount apply to both semaglutide and tirzepatide?

Yes. MEDVi offers a first-month introductory rate of $179 for semaglutide injection and $279 for tirzepatide injection. Starting in month two, you pay the standard refill rate of $299 or $399 per month, respectively.

Can I switch from MEDVi's injection to tablet mid-treatment without restarting?

MEDVi offers both injection and tablet routes for semaglutide. Switching routes typically requires a new clinical evaluation and prescription. Contact MEDVi directly to confirm the transition process and whether the first-month discount applies again.

Does PlexusDx require a minimum commitment for the month-to-month plan?

No. PlexusDx month-to-month plans carry no minimum commitment and permit cancellation anytime. The three-month and six-month commitment tiers offer lower per-month rates in exchange for a defined enrollment period.

What happens if I experience side effects and need to pause treatment on a prepaid plan?

Prepaid plans require upfront payment for multiple months. If you pause or discontinue treatment mid-cycle, refund and credit policies vary by provider. Review cancellation and refund terms at checkout before selecting a prepaid option.

Sources

• PlexusDx Weight Management Protocols pricing page, accessed September 4, 2026
• PlexusDx product pages (semaglutide injection, tirzepatide injection, oral formulations, microdose GLP-1), accessed September 4, 2026
• BrightMeds promotional pricing page, accessed September 4, 2026
• MEDVi checkout flow, completed September 4, 2026
• Trustpilot review data for BrightMeds, MEDVi, and PlexusDx, captured September 4, 2026

Compounded medication disclosure: Compounded medications are not FDA-approved. FDA does not review compounded drugs before marketing for safety, effectiveness, or quality. A licensed clinician determines whether a prescription is appropriate for an individual patient. PlexusDx works with licensed 503A compounding pharmacies.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.